Organogenesis Holdings is a regenerative medicine company engaged on the development, manufacture and commercialization of solutions for the Advanced Wound Care and Surgical and Sports Medicine markets. In the Advanced Wound Care market, Co. engages on the development and commercialization of a portfolio of cellular and acellular wound care offerings that treat patients from the earliest indication of impaired healing to wound closure. In the Surgical and Sports Medicine market, Co. engages on the development and commercialization of products that support the healing of musculoskeletal injuries, including chronic degenerative conditions such as osteoarthritis and tendonitis. We show 18 historical shares outstanding datapoints in our ORGO shares outstanding history coverage, used to compute ORGO market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing ORGO market cap history over the course of time is important for investors
interested in comparing ORGO's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of ORGO versus a peer is one thing; comparing
ORGO market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like ORGO can fluctuate over the course of history.
With this page we aim to empower investors researching ORGO by allowing them to research the ORGO market cap history. |
Free ORGO Email Alerts:
Video: The Importance of Market Cap
